NCT06047990

Brief Summary

The rationale of the study is to explore the safety and efficacy of percutaneously performed endobiliary cryobiopsy in patiens with histologically unverified biliary stenosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

September 21, 2023

Status Verified

September 1, 2023

Enrollment Period

1.2 years

First QC Date

September 11, 2023

Last Update Submit

September 19, 2023

Conditions

Keywords

cryobiopsybiliary obstructionpercutaneous transhepatic drainage

Outcome Measures

Primary Outcomes (3)

  • Sensitivity of biopsy sampling to detect malignancy

    Comparison of sensitivity of endobiliary cryobiopsy and forceps biopsy for detection of malignancy.

    up to month 12 or death of the patient

  • Quality of samples collected by endobiliary cryobiopsy and forceps biopsy - weight

    Comparison of weight (in milligrams) of samples collected by endobiliary cryopsy and forceps biopsy. Each sample will be weighed separately and one measurement value will be recorded for each sample.

    up to month 12 or death of the patient

  • Quality of samples collected by endobiliary cryobiopsy and forceps biopsy - size

    Comparison of the size weight (in millimeters) of samples collected by endobiliary cryopsy and forceps biopsy. Each sample will be weighed in two dimensions on slide.

    up to month 12 or death of the patient

Study Arms (2)

Cryobiopsy

EXPERIMENTAL

In randomised patients in experimental arm was initially performed cryobiopsy (3 samples) and cosequently forceps biopsy (6 samples) with 5.2F or 7.5F forceps. Both sampling techniques were performed during one procedure of percutaneous transhepatic drainage under fluoroscopic control.

Device: Cryobiopsy catheter

Forceps biopsy

ACTIVE COMPARATOR

In randomised patients in control arm was initially performed forceps biopsy (6 samples) with 5.2F or 7.5F forceps and cosequently cryobiopsy (3 samples). Both sampling techniques were performed during one procedure of percutaneous transhepatic drainage under fluoroscopic control.

Device: Cryobiopsy catheter

Interventions

Comparison of endobiliary forceps biopsy and cryobiopsy of biliary stenosis during percutaneous transhepatic drainage.

CryobiopsyForceps biopsy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • biliary stenosis of unknown etiology
  • unsuccessful or unfeasable ERCP
  • indicated percutaneous transhepatic drainage

You may not qualify if:

  • histologically verified biliary stenosis
  • INR ≥ 1,5

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brno University Hospital

Brno, 62500, Czechia

RECRUITING

Central Study Contacts

Tomáš Andrašina, MD

CONTACT

Tomáš Rohan, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Randomization was performed by the Institute of Biostatistics and Analysis of Masaryk University Brno.
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Tomáš Andrašina, MD, PhD; Assistant professor, Head of Non-vascular interventions and Computed Tomography of the Department of Radiology and Nuclear Medicine

Study Record Dates

First Submitted

September 11, 2023

First Posted

September 21, 2023

Study Start

June 1, 2023

Primary Completion

July 31, 2024

Study Completion

December 31, 2024

Last Updated

September 21, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations